Pharmaceutical, Diagnostic Companies Launch Research Into Zika Virus Vaccine, Test
Associated Press: Drugmaker Sanofi Pasteur launches effort for Zika vaccine
“Drugmaker Sanofi Pasteur announced Tuesday it is launching an effort to research and develop a vaccine to prevent the Zika virus, after the World Health Organization declared a global emergency over its explosive spread across the Americas…” (2/2).
Bloomberg Business: Sanofi to Work on Zika Vaccine as Health Emergency Declared
“…The French drugmaker plans to harness its work against dengue fever to attack Zika, a virus from the same family, Sanofi said in a statement on Tuesday…” (Fourcade, 2/2).
Financial Times: Sanofi leads hunt for Zika vaccine
“…The company said its R&D and industrial infrastructure could be ‘rapidly leveraged’ to help understand the spread of Zika and potentially speed identification of a vaccine candidate for development…” (Ward, 2/2).
Reuters: Sanofi launches hunt for Zika vaccine as disease fears grow
“…So far, the only groups with firm plans to develop a Zika vaccine are small biotech companies and academic institutions, although GlaxoSmithKline has said it is concluding feasibility studies to evaluate if its vaccine technology is suitable…” (Vidalon/Hirschler, 2/2).
Washington Post: A Md. biotech firm claims it can track Zika virus by testing mosquitoes
“…After a 21-day sprint, GenArraytion claims to have come up with a molecular test that can spot the [Zika] virus in mosquitoes before it infects humans. The goal is to give health agencies a better way to map the virus…” (Gregg, 2/1).